7T39
Co-crystal structure of human PRMT9 in complex with MT221 inhibitor
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | ALS BEAMLINE 5.0.2 |
Synchrotron site | ALS |
Beamline | 5.0.2 |
Temperature [K] | 100 |
Detector technology | PIXEL |
Collection date | 2019-09-14 |
Detector | DECTRIS PILATUS3 6M |
Wavelength(s) | 0.97741 |
Spacegroup name | P 1 21 1 |
Unit cell lengths | 64.138, 82.735, 65.836 |
Unit cell angles | 90.00, 97.94, 90.00 |
Refinement procedure
Resolution | 49.060 - 2.810 |
R-factor | 0.2301 |
Rwork | 0.228 |
R-free | 0.26860 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 6pdm |
RMSD bond length | 0.003 |
RMSD bond angle | 1.192 |
Data reduction software | HKL-3000 |
Data scaling software | SCALEPACK |
Phasing software | PHASER |
Refinement software | REFMAC (5.8.0258) |
Data quality characteristics
Overall | Inner shell | Outer shell | |
Low resolution limit [Å] | 50.000 | 50.000 | 2.850 |
High resolution limit [Å] | 2.800 | 7.590 | 2.800 |
Rmerge | 0.162 | 0.077 | 1.008 |
Rmeas | 0.168 | 0.080 | 1.052 |
Rpim | 0.043 | 0.021 | 0.295 |
Total number of observations | 241023 | ||
Number of reflections | 16704 | 876 | 812 |
<I/σ(I)> | 4 | ||
Completeness [%] | 99.6 | 100 | 96.7 |
Redundancy | 14.4 | 14.2 | 11.3 |
CC(1/2) | 0.996 | 0.857 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, SITTING DROP | 7.4 | 291 | 25%(w/v) PEG3350, 0.2M Ammonium Acetate, 0.1M Bis-Tris pH5.5 |